TransCode Therapeutics announced the retirement of CFO Tom Fitzgerald, who helped guide the company through its IPO and key clinical developments. John Tattory, with over 25 years of financial leadership in biotech and pharma, will serve as interim CFO. This leadership change comes as TransCode continues advancing its cancer therapy pipeline, including its lead candidate TTX-MC138. The transition aims to maintain financial stability and support ongoing growth in the immuno-oncology sector.
Kroger is set to release its earnings report on September 11, 2026, with analysts expecting earnings per share around $1.05-$1.06 and revenues near $34.64-$34.68 billion. Despite growth in digital sales and fresh product categories, the company faces...
On the day GameStop released its earnings report, an insider purchased $1 million worth of company shares. This move suggests strong confidence in the company's future despite market uncertainties. Insider buying often signals positive expectations a...
Roth Capital has reiterated its Buy rating for Smith Micro Software following the company's announcement of an expanded multi-year agreement with a major U.S. mobile operator. This deal strengthens Smith Micro's long-term partnership and focuses on a...
Vince Holding Corp. reported a strong Q2 with earnings per share of $1.02, far exceeding the $0.27 consensus estimate, marking a 277.78% earnings surprise. Revenue reached $81.79 million, up 11.7% year-over-year and surpassing estimates, driven by st...
BHP, a leading global mining company, received a "Neutral" rating from Citigroup due to ongoing labor disputes and potential legal challenges involving up to 7,000 workers. These issues pose risks to operational stability, despite BHP's strong market...
